AVITA Medical (RCEL) Receivables (2018 - 2025)
AVITA Medical (RCEL) posted Receivables of $9.0 million for Q3 2025, down 20.54% on a QoQ basis from $11.3 million in Q2 2025, and down 13.33% year-over-year from $10.4 million in Q3 2024.
AVITA Medical (RCEL) Receivables (2018 - 2025) Analysis & Trends
AVITA Medical's Receivables history runs 8 years deep, the most recent figure standing at $9.0 million for Q3 2025.
- Quarterly Receivables fell 13.33% year-over-year to $9.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $9.0 million (down 13.33% YoY) and the FY2025 annual result came in at $9.1 million, down 23.27% from the prior year.
- Receivables was $9.0 million for Q3 2025 at AVITA Medical, down from $11.3 million in the prior quarter.
- Across five years, Receivables topped out at $12.0 million in Q1 2025 and bottomed at -$215000.0 in Q3 2021.
- A 5-year average of $6.3 million and a median of $6.2 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables tumbled 107.87% — and 2023, when it jumped 6968.87%.
- AVITA Medical's Receivables stood at $3.4 million in 2021, then plunged by 96.91% to $106000.0 in 2022, then soared by 6968.87% to $7.5 million in 2023, then soared by 56.56% to $11.7 million in 2024, then retreated by 23.17% to $9.0 million in 2025.
- Business Quant data shows RCEL's Receivables at $9.0 million in Q3 2025, $11.3 million in Q2 2025, and $12.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.01 Mn |
| Jun 30, 2025 | 11.34 Mn |
| Mar 31, 2025 | 12.05 Mn |
| Dec 31, 2024 | 11.73 Mn |
| Sep 30, 2024 | 10.40 Mn |
| Jun 30, 2024 | 8.81 Mn |
| Mar 31, 2024 | 7.11 Mn |
| Dec 31, 2023 | 7.49 Mn |
| Sep 30, 2023 | 6.08 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 4.35 Mn |
| Jun 30, 2022 | 338,000.00 |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 3.43 Mn |
| Sep 30, 2021 | -215,000.00 |
| Jun 30, 2021 | 6.96 Mn |
| Mar 31, 2021 | 5.48 Mn |
| Dec 31, 2020 | 2.38 Mn |